Sentences with phrase «product liability action by»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.

You shall indemnify The Endocrine Society and its directors, officers, employees, agents, contractors and licensors («The Endocrine Society Indemnitees») against all claims, actions, suits, and other proceedings («Claims») arising out of or incurred in connection with the Site and your use of the Site, your fraud, violation of law, negligence, willful misconduct, or any other use of the Site, the User Materials, the Site Materials, the services, products, information and other materials on and in and made available through the Site, (except to the extent attributable to The Endocrine Society), or any breach by you of these Terms and Conditions and shall indemnify and hold the Endocrine Society Indemnitees harmless from and against all judgments, losses, liabilities, damages, costs, and expenses (including without limitation reasonable attorneys» fees and attorneys» disbursements) arising out of or incurred in connection with such Claims.

If a defect in a product is found to have been a cause of a child's flame - burn injury, the manufacturer of the product and anyone in the chain of the product's distribution may be found liable for the injuries suffered by the child in a product - liability action.

Many of the patients affected by NSF / NSD have filed gadolinium lawsuits or joined class action gadolinium lawsuits claiming that the manufacturers of gadolinium - based contrast agents were negligent or violated product liability and / or pharmaceutical liability statutes.

The manufacturer of a product that contains a defect in the product's manufacture or design or as a result of the manufacturer's or seller's failure to warn of the product's dangers may be held liable in a product liability action for injuries sustained by a child as a result of the child's use of or exposure to the product.

Under certain circumstances, product - liability actions may be brought to address injuries sustained by a child while using a pool.

In either case, the manufacturer of the defective shield or grate and anyone in the chain of the product's distribution may be held liable in a product - liability action for the flame - burn injuries suffered by the child as a result of the defect.

Stories are organized not by publications but by practice areas, with five main practice areas to start: Appellate, Corporate and Securities, Intellectual Property, Labor & Employment, and Class Actions and Product Liability.

The high court is also unimpressed with the fact that the drug giving rise to the product liability was distributed by a California company, presumably because the cause of action in question in the case was brought against the manufacturer as a strict liability defective product claim, rather than as a claim against a seller of the product arising from a warranty that the product was free of defects arising under the Uniform Commercial Code or an express warranty.

If you or a family member has been injured by a dangerous product, or suffered damages related to product liablility, you can hand over your concerns about legal matters to the personal injury product liability attorneys at Action Law Offices.

At Action Law Offices in Racine and Milwaukee, Wisconsin, our product liability lawyers have the experience and the resources to investigate accidents caused by defective products.

Drawing on attorneys from across practice areas and offices, Weil has developed an impressive track record advising with respect to shareholder claims and demands for litigation, internal whistleblower complaints, class and collective actions brought by employees relating to pay, worker classification, and discrimination claims, product liability issues and recalls, privacy rights, intellectual property disputes (patents, trademarks, copyrights, and trade secrets), regulatory investigations commenced by the U.S. Federal Trade Commission, U.S. Department of Labor, U.S. Department of Justice, and state attorneys general, and major disputes with suppliers and competitors.

It might start by working on communications issues surrounding damaged credibility, management transitions, bankruptcies, litigation, regulatory actions, rumour management, earnings shortfalls, restructurings and product liability situations.

These law firms were a reaction to the rise in Plaintiff's law firms retooled to gather the technical information and expertise (often gathered by government agencies and burgeoning universities fueled by GI Bill enrollment) that was needed to prosecute product liability cases and mass torts and to manage massive amounts of discovery and class action lawsuit in this complex litigation.

A person who has been injured by such a product may be entitled to recover damages from certain parties involved in the product's production and release to the public through the institution of a product liability action.

The Killino Firm's auto accident and defective - products lawyer has extensive experience with cases arising out of injuries and deaths caused by motor - vehicle defects, including a product - liability action that led to the recall of 450,000 defective Chinese - manufactured tires.

Represented manufacturer in defense of numerous product liability actions, including insurance subrogation cases, alleging loss due to fires caused by alleged defective clothes dryers

Led by co-founders and senior partners Mary Quinn Cooper and William S. Leach, ECSL specializes in commercial litigation, products liability, class actions and complex civil litigation on a regional and national level for clients ranging from small privately owned companies and government entities to Fortune 100 companies.

735 ILCS 5/13-213 (c): Alteration, modification or change No product liability action based on any theory or doctrine to recover for injury or damage claimed to have resulted from an alteration, modification, or change of the product unit after the date of first sale, lease, or delivery of possession of the product unit to its initial user, consumer, or other nonseller may be limited or barred by subsection (b) if the action is commenced within the applicable limitation period; and, in any event, within 10 years from the date the alteration, modification, or change was made, unless defendant expressly has warranted or promised the product for a longer period and the action is brought within that period.

Generally, product - liability actions are brought by plaintiffs who have suffered an injury that was caused by a defect in a product's design or manufacture.

Defense of Corning in Massachusetts state and federal court product liability actions alleging rheumatologic and immunologic disorders allegedly caused by silicone gel breast implants

People often sustain injuries as a result of their own carelessness, however, when an injury is caused by the negligence of another individual or entity, medical error, or a defect in a product, the injured person may be able to recover financial compensation from the responsible parties through the institution of a negligence, product liability, or medical malpractice action.

The firm firm was recognized as Best Lawyers ® «Best Law Firms» by U.S. News & World Report and received the prestigious Tier One ranking for San Diego in the in the categories of Commercial Litigation; Litigation — Construction; Litigation — Real Estate; Mass Torts Litigation / Class Actions; Personal Injury Litigation — Plaintiffs and Product Liability Litigation — Plaintiffs.

Product - liability actions for inherently dangerous products take into account the fact that the dangers of such products are not generally known or understood by the average consumer — and certainly not by their children.

Defense of Pennwalt in Massachusetts federal court product liability action alleging business destroyed by fire allegedly caused by paint - stripping compound

In almost all products liability actions, as was the case above, the manufacturer will attempt to evade liability by any means possible.

The Killino Firm's car - accident and defective - products lawyers have extensive experience with cases arising out of injuries and deaths caused by motor - vehicle defects, including a product - liability action that led to the recall of 450,000 defective Chinese - manufactured tires.

If you have been injured or a family member has been killed in an accident and you suspect that your injury or loved one's death was caused by someone's negligence or a defective product, you may be able to recover damages through the institution of a product liability, negligence, or wrongful death action.

Damages for injuries and deaths caused by vehicle or vehicle safety equipment defects are brought as product liability actions against the manufacturer, designer, suppliers, assemblers, and others involved in the production of the defective vehicle or equipment and its release to the market.

In addition to filing private complaints, our Atlanta product liability lawyers also file class action lawsuits when many people have been injured or killed by the same product.

This year's survey found that labor and employment (particularly, wage and hour litigation), consumer fraud, product liability, and antitrust matters collectively accounted for two - thirds of class action spending by respondents, with data privacy and security matters lurking as a potential next wave in 2018.

They are followed by product liability, securities, and antitrust matters, which have increased since 2012 and now collectively account for another third of class actions.

Lead trial counsel in the first medical products class action / common issues trial tried to verdict in Canada (146 trial days), successfully defending one of the world's leading manufacturers of life - saving cardiac devices in a national class action claiming more than a billion dollars in damages (awarded 2013 Canadian Product Liability Impact Case of the Year by LMG Life Sciences)

(There's probably a lawyer out there who sees a class - action products liability suit against YouTube by its users for YouTube failing to warn its users of this foreseeable danger of a lawsuit that gives outsiders access to users private information as part of discovery.)

The Drug and Medical Device Product Liability Deskbook includes: detailed coverage of: warning - related claims and defenses; other information - based theories; strict liability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanLiability Deskbook includes: detailed coverage of: warning - related claims and defenses; other information - based theories; strict liability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability; FDA - related per se liability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability; preemption of common law tort claims by the Food, Drug & Cosmetic Act and FDA regulations; class actions in drug and medical device litigation; theories of liability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other importanliability asserted against entities other than manufacturers; practical issues involving litigation management; the use of expert witnesses; and many other important topics.

He also defends manufacturing clients against products liability and other claims by consumers, including class actions and claims based upon alleged deceptive advertising and marketing.

To the maximum extent permitted by applicable law, in no event will RealtyForSale.ca be liable for any damages, including without limitation, loss of profits, compensatory, consequential, direct, exemplary, indirect, punitive, incidental, special or consequential damages, or any liability which you may suffer or which you may have to a third party, arising from or relating to these Terms, access or use of the Website, with the delay or inability to use the Website, registration, for any content, postings, information, services, programs, products and materials available on or through the Website, or for any actions or inactions of our partners, whether based in contract, tort, strict liability or otherwise, even if such damages were foreseeable or if the Website has been advised of the possibility of such damages.